Figure 2.
Metformin use increases survival in diabetics with PDAC. Overall survival 4.2 (s.d. 7.2) vs. 5.5 (s.d. 8.2) months, P<0.01. PDAC, pancreatic ductal adenocarcinoma.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.